NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc., trading under the ticker BRPA, is associated with Big Rock Partners Acquisition Corp., a blank check company sponsored by Big Rock Partners LLC that completed its initial public offering in 2017. The SPAC targeted the healthcare and pharmaceutical sector, ultimately pursuing a business combination with NRX Pharmaceuticals, a clinical-stage biopharmaceutical company focused on treatments for central nervous system disorders and critical care conditions. The 10-Q filing submitted on May 15, 2018, with accession number 0001654954-18-005418, reflects a quarterly disclosure during the company's active operational period following its public listing. Sign up for full data, filings, and deal analytics on SpacDesk.